GSK's Curbs On Parallel Trading May Be Illegal: Court
The ruling by the European Court of Justice, which holds that a pharmaceutical company is abusing its dominant position if it refuses to meet “ordinary” orders by wholesalers in order to prevent parallel exports, comes in a long-running court battle Glaxo subsidiary GlaxoSmithKline AEVE has been facing over the practice.
Whether Glaxo's orders...
Already a subscriber? Click here to login